Sebastian M. Spencer

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance

A. Westwell, J. Scalici, Ranganatha R. Somasagara, 2017, Oncogene.

Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.

A. Westwell, K. Tripathi, Komaraiah Palle, 2016, Bioorganic & medicinal chemistry letters.

Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancer.

G. Piazza, J. Scalici, Ranganatha R. Somasagara, 2016, Biochemical and biophysical research communications.